Pathstone Family Office’s AbCellera Biologics ABCL Stock Holding History

Pathstone Family Office’s Portfolio ABCL Stock Details ABCL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$80K	Buy
2023 Q2	$96.4K	Sell
2023 Q1	$119K	Sell
2022 Q4	$356K	Sell
2022 Q3	$356K	Buy
2022 Q2	$199K	Buy
2022 Q1	$142K	Buy
2021 Q4	$187K	Buy
2021 Q3	$240K	Buy